A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC).
Clinical trial NCT05975645 · TERMINATED
Trial details
- NCT number
- NCT05975645
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-15
- Primary completion
- 2025-06-04
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.